Purchase Order 75N91025P00122

Award Date 1/10/25
Potential Completion Date 1/9/26
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,999.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment and reagents. The contract is for the delivery of unspecified laboratory equipment, with a period of performance through September 7, 2024. While not awarded under a set-aside program, Miltenyi Biotec has extensive...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of goods. The $211,830 contract is for the provision of Miltenyi's biotechnology products and services to support biomedical research and cell and gene therapy, including instruments, reagents, kits, and antibodies. The award does not have a set-aside...
This is a $13,092 firm fixed-price purchase order awarded to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer, by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for a SERVICE CONTRACT FOR AUTOMACS PRO SEPARATOR with a completion date of December 14, 2020. Miltenyi Biotec, a global biotechnology company, has served as a prime contractor on numerous contracts with federal agencies,...
This is a $4,250 fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of biotechnology products. The contract is not set aside and runs through May 2011. Miltenyi Biotec provides specialized scientific instruments, reagents, and services to support biomedical research, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables under this award...
This is a $8,379.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of biomaterials. The award is not designated as a set-aside contract. Miltenyi Biotec is a prime contractor that frequently supports federal biomedical research programs with its specialized cell separation, analysis, and processing technologies, including flow cytometers, cell sorters, and...
This is a $53,081.29 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of biotechnology products. The contract, which does not have a set-aside designation, provides for the delivery and installation of specialized laboratory equipment such as flow cytometers, cell sorters, and cell processing systems, as well as related reagents and consumables. Many of the contract's...
This $4,884 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is not associated with a set-aside. Under this award, Miltenyi Biotec will supply the NIH Clinical Center with proprietary CliniMACS cell isolation reagents and consumables required for Good...
This $6,929.75 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized instruments, reagents, and services for biomedical research and cell therapy development. The contract does not have a set-aside designation. Miltenyi Biotec is delivering a range of products and services to support NIAID's research programs, particularly in areas such as cancer,...
This is a $23,230 firm fixed-price purchase order contract awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute on Aging, a civilian federal agency. The contract delivers specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation, including flow cytometers, cell sorters, tissue dissociators, automated cell separation systems, and associated consumables. Miltenyi Biotec has an...
This is a $19,325.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is for the provision of specialized scientific equipment and associated maintenance services,...

This is a $18,450 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The contract is for a service agreement with a completion date of January 9, 2026. Miltenyi Biotec, which is a foreign-owned, for-profit manufacturer, has extensive experience as a prime contractor for numerous federal agencies, including the NIH, VA, FDA, DoD, CDC, and USDA. This award is not associated with any set-aside program. The contract supports the NCI's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Miltenyi Biotec also holds a $2.3 million indefinite delivery contract (IDC) with the NIH Clinical Center to supply proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options to extend to 2027.

Generated 12/7/24, 9:40 AM